Your browser doesn't support javascript.
loading
Detection of SARS-CoV-2 in the community by nucleic acid amplification testing of saliva
Filippo Fronza; Nelli Groff; Angela Martinelli; Beatrice Zita Passerini; Nicolo Rensi; Irene Cortelletti; Nicolo Vivori; Valentina Adami; Anna Helander; Simone Bridi; Michael Pancher; Valentina Greco; Sonia Iolanda Garritano; Elena Piffer; Lara Stefani; Veronica De Sanctis; Roberto Bertorelli; Serena Pancheri; Lucia Collini; Alessandro Quattrone; Maria Rosaria Capobianchi; Giancarlo Icardi; Guido Poli; Patrizio Caciagli; Antonio Ferro; Massimo Pizzato.
Afiliación
  • Filippo Fronza; University of Trento
  • Nelli Groff; University of Trento
  • Angela Martinelli; University of Trento
  • Beatrice Zita Passerini; University of Trento
  • Nicolo Rensi; University of Trento
  • Irene Cortelletti; University of Trento
  • Nicolo Vivori; University of Trento
  • Valentina Adami; University of Trento
  • Anna Helander; University of Trento
  • Simone Bridi; University of Trento
  • Michael Pancher; University of Trento
  • Valentina Greco; University of Trento
  • Sonia Iolanda Garritano; University of Trento
  • Elena Piffer; University of Trento
  • Lara Stefani; University of Trento
  • Veronica De Sanctis; University of Trento
  • Roberto Bertorelli; University of Trento
  • Serena Pancheri; Azienda Provinciale per i Servizi Sanitari, Trento
  • Lucia Collini; Azienda Provinciale per i Servizi Sanitari, Trento
  • Alessandro Quattrone; University of Trento
  • Maria Rosaria Capobianchi; National Institute for Infectious Diseases "L. Spallanzani", Roma
  • Giancarlo Icardi; University of Genova
  • Guido Poli; Vita-Salute San Raffaele University, Milano
  • Patrizio Caciagli; Azienda Provinciale per i Servizi Sanitari, Trento
  • Antonio Ferro; Azienda Provinciale per i Servizi Sanitari, Trento
  • Massimo Pizzato; University of Trento
Preprint en En | PREPRINT-MEDRXIV | ID: ppmedrxiv-21263644
ABSTRACT
Efficient wide-scale testing for SARS-CoV-2 is crucial for monitoring the incidence of the infection in the community. The gold standard for COVID-19 diagnosis is the molecular analysis of epithelial secretions from the upper respiratory system captured by nasopharyngeal (NP) swabs, which requires the intervention of trained personnel. Given the ease of collection, saliva has been proposed as a possible substitute to support testing at the population level. Here we describe the set-up of a laboratory, in an academic context, for the high-throughput screening of SARS-CoV-2 in the saliva from the community. A novel saliva collection device was designed to favour the safe and correct acquisition of the sample as well as the processivity of the downstream molecular analysis. To test the performance of the system,1025 paired saliva and nasopharyngeal samples were collected from individuals recruited at a public drive through testing facility and analysed in parallel. An overall moderate concordance (68%) between the two tests was found, with evidence that neither test can diagnose the infection in 100% of the cases. While the two tests performed equally well in symptomatic individuals, their discordance was mainly restricted to samples from convalescent individuals. The saliva test was at least as effective as NP swabs in asymptomatic individuals recruited for contact tracing. Our study, therefore, indicates that saliva testing can be a reliable tool for wide-scale COVID-19 screening in the community.
Licencia
cc_by_nc_nd
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Tipo de estudio: Diagnostic_studies / Observational_studies Idioma: En Año: 2021 Tipo del documento: Preprint
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-MEDRXIV Tipo de estudio: Diagnostic_studies / Observational_studies Idioma: En Año: 2021 Tipo del documento: Preprint